Discovery has a new Editor-in-Chief: Nirmish Singla, M.D., M.Sc. He is the second to hold this position, after Patrick C. Walsh, M.D. 

“I am stepping down after more than 25 years,” says Walsh, Discovery’s founding Editor-in-Chief, “and am thrilled that Nirmish has accepted this position. He was selected because of his scholarship, depth of knowledge in all areas of urologic oncology, and dedication to excellence. In addition to being an outstanding surgeon and clinician, he wears many hats: Director of Translational Research in Genitourinary Oncology, Director of the Kidney Cancer Program, Co-Director of the Upper Tract Urothelial Cancer (UTUC) Program, and Vice Chair and Physician Advisor for Quality, Safety & Service at the Brady. I look forward to his many future years of leadership.” 

Singla earned his B.S.E in Biomedical Engineering from the University of Michigan, and his M.D. from the University of Michigan Medical School. He completed his residency in Urologic Surgery at the University of Texas Southwestern (UTSW) Medical Center, and spent an extra year there as a postdoctoral research fellow in urologic oncology, with a specialized focus on translational research in kidney cancer. During this time, he also earned a Master of Science in Clinical Science degree through the Center for Translational Medicine at UTSW. He then completed an advanced surgical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. 

When he joined the Brady in 2020, Singla hit the ground running: conducting clinical and translational research, teaching residents and fellows, and caring for patients. The lead principal investigator on multiple federal research grants and co-author of more than 300 articles and textbook chapters, he has established an international reputation as a leader in urologic oncology. 

“I think Discovery’s name is very fitting,” says Singla. “It is the legacy that Dr. Walsh championed and embodies the core research mission of the Brady: making new discoveries to advance the field and improve the lives of patients. The Brady is unique, as we have renowned experts representing every subspecialty area in urology. The Brady is a leader and forward-thinking institute of excellence that strives to push boundaries, expand horizons, and challenge the current dogma in our field. I look forward to showcasing the ever-growing strengths and future directions of the Brady in Discovery.” 

A major part of the Brady’s success, he adds, has been made possible because of philanthropy. “It is wonderful to see so much support from the patients and friends of the Brady. That is something really special and part of Dr. Walsh’s strong legacy, as well. It is my honor and privilege to carry this legacy forward by taking the helm of Discovery.”